-
Something wrong with this record ?
Parameter optimization in a continuous direct compression process of commercially batch-produced bisoprolol tablets
J. Lyytikäinen, P. Stasiak, T. Kubelka, T. Olenius, O. Korhonen, J. Ketolainen, T. Ervasti
Language English Country Netherlands
Document type Journal Article
- MeSH
- Bisoprolol * MeSH
- Technology, Pharmaceutical * MeSH
- Powders MeSH
- Drug Compounding MeSH
- Tablets MeSH
- Pressure MeSH
- Publication type
- Journal Article MeSH
Continuous tablet manufacturing is a competitive option to replace the traditional batch manufacturing approach. The aim of this study was to evaluate technology transfer from batch-based direct compression of a commercial tablet formulation to continuous direct compression without changes to the composition of the formulation. Some powder studies were conducted with the raw materials and multi-tip punches were utilized in the tableting studies. To lower the high level of tablet weight variability that was evident during preliminary tests, a process parameter optimization was performed using an experimental design with different rpm values of force feeder and mixer impeller. By selecting the most appropriate settings of these parameters for the studied product, the weights of the tablets could be controlled adequately to meet the specification criteria. The functionality of the best-performing parameter settings was investigated with a three-hour-long tableting run. The tablets were evaluated with the same quality criteria as the commercial batch-produced tablets, and they passed all the tests performed in this study. Despite the challenging material properties according to the flowability tests, production of tablets with the desired quality was achieved using the original composition with continuous direct compression.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22032589
- 003
- CZ-PrNML
- 005
- 20230131151508.0
- 007
- ta
- 008
- 230120s2022 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ijpharm.2022.122355 $2 doi
- 035 __
- $a (PubMed)36341918
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Lyytikäinen, Jenna $u School of Pharmacy, PromisLab, University of Eastern Finland, Kuopio, Finland. Electronic address: jenna.lyytikainen@uef.fi
- 245 10
- $a Parameter optimization in a continuous direct compression process of commercially batch-produced bisoprolol tablets / $c J. Lyytikäinen, P. Stasiak, T. Kubelka, T. Olenius, O. Korhonen, J. Ketolainen, T. Ervasti
- 520 9_
- $a Continuous tablet manufacturing is a competitive option to replace the traditional batch manufacturing approach. The aim of this study was to evaluate technology transfer from batch-based direct compression of a commercial tablet formulation to continuous direct compression without changes to the composition of the formulation. Some powder studies were conducted with the raw materials and multi-tip punches were utilized in the tableting studies. To lower the high level of tablet weight variability that was evident during preliminary tests, a process parameter optimization was performed using an experimental design with different rpm values of force feeder and mixer impeller. By selecting the most appropriate settings of these parameters for the studied product, the weights of the tablets could be controlled adequately to meet the specification criteria. The functionality of the best-performing parameter settings was investigated with a three-hour-long tableting run. The tablets were evaluated with the same quality criteria as the commercial batch-produced tablets, and they passed all the tests performed in this study. Despite the challenging material properties according to the flowability tests, production of tablets with the desired quality was achieved using the original composition with continuous direct compression.
- 650 12
- $a bisoprolol $7 D017298
- 650 _2
- $a tablety $7 D013607
- 650 _2
- $a prášky, zásypy, pudry $7 D011208
- 650 _2
- $a tlak $7 D011312
- 650 12
- $a farmaceutická technologie $7 D013678
- 650 _2
- $a příprava léků $7 D004339
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Stasiak, Pawel $u Zentiva, Prague, Czech Republic. Electronic address: pawel.stasiak@zentiva.com
- 700 1_
- $a Kubelka, Tomáš $u Zentiva, Prague, Czech Republic. Electronic address: Tomas.Kubelka@zentiva.com
- 700 1_
- $a Olenius, Tino $u School of Pharmacy, PromisLab, University of Eastern Finland, Kuopio, Finland. Electronic address: tino.olenius@uef.fi
- 700 1_
- $a Korhonen, Ossi $u School of Pharmacy, PromisLab, University of Eastern Finland, Kuopio, Finland. Electronic address: ossi.korhonen@uef.fi
- 700 1_
- $a Ketolainen, Jarkko $u School of Pharmacy, PromisLab, University of Eastern Finland, Kuopio, Finland. Electronic address: jarkko.ketolainen@uef.fi
- 700 1_
- $a Ervasti, Tuomas $u School of Pharmacy, PromisLab, University of Eastern Finland, Kuopio, Finland. Electronic address: tuomas.ervasti@uef.fi
- 773 0_
- $w MED00002359 $t International journal of pharmaceutics $x 1873-3476 $g Roč. 628, č. - (2022), s. 122355
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36341918 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230120 $b ABA008
- 991 __
- $a 20230131151504 $b ABA008
- 999 __
- $a ok $b bmc $g 1891387 $s 1183924
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2022 $b 628 $c - $d 122355 $e 20221029 $i 1873-3476 $m International journal of pharmaceutics $n Int. j. pharm. $x MED00002359
- LZP __
- $a Pubmed-20230120